Joel S. Smith
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Joel S. Smith
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Medical Specialties | 13 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Joel S. Smith via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Datascope Corp.
Datascope Corp. Electronic Equipment/InstrumentsElectronic Technology Datascope Corp. manufactures and distributes surgical equipments. The company provides medical instruments such as intra aortic balloon pumps and catheters for use in cardiology, radiology, anesthesiology, cardiovascular, vascular surgery and emergency medicine. It also develops vascular grafts and patches for reconstructive blood vessel surgeries as well as multifunction patient monitoring devices. The company was founded in 1964 as New York Corp. It is headquartered in Montvale, NJ. | Electronic Equipment/Instruments | Chief Executive Officer | |
Inamed Corp.
Inamed Corp. Medical SpecialtiesHealth Technology Inamed Corp. developed and manufactured breast implants, wrinkle prevention & obesity solutions. Its products were available through its two business divisions: INAMED Aesthetics, and INAMED Health. The company offered breast implants for augmentation, reconstruction surgeries, invasive surgeries for sustained weight loss and other dermal products to correct facial wrinkles. INAMED was headquartered in Santa Barbara, CA. | Medical Specialties | Chief Tech/Sci/R&D Officer Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
RAYMOND JAMES FINANCIAL, INC. | Investment Managers | Private Equity Analyst | |
INOGEN, INC. | Medical Specialties | Director/Board Member Investor Relations Contact | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
LOMBARD MEDICAL, INC. | Medical Specialties | Director/Board Member | |
Symbiomix Therapeutics LLC
Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | Biotechnology | Director/Board Member | |
Abingworth LLP
Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Private Equity Investor | |
Loyola University of Chicago | College/University | Masters Business Admin Masters Business Admin | |
INSEAD | College/University | Masters Business Admin | |
University of California, Santa Barbara | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
NEUROPACE, INC. | Medical Specialties | Director/Board Member | |
Chroma Therapeutics Ltd.
Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
Direct Conversion AB
Direct Conversion AB Medical SpecialtiesHealth Technology Direct Conversion AB manufactures and supplies X-Ray detectors such as cadmium telluride (CdTe) detectors. Its products include XC-THOR, XC-HYDRA, XC-TDI, XC-ACTAEON, SNAP 225, SNAP 150 and SNAP 100X2. The firm’s products are used in the dental, medical, welding, industrial, food and security industries. The company was founded in 1997 and is headquartered in Danderyd, Sweden. | Medical Specialties | Director/Board Member | |
MEDIAN TECHNOLOGIES | Medical/Nursing Services | Director/Board Member | |
The University of Exeter | College/University | Undergraduate Degree | |
VERONA PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
IMI Intelligent Medical Implants AG
IMI Intelligent Medical Implants AG Medical DistributorsDistribution Services IMI Intelligent Medical Implants is a medical technology company. The goal of the company is to develop and market an intelligent retinal implant system for degenerative retinal disorders such as Retinitis Pigmentosa or Macular Degeneration and thereby make a contribution to the improvement of the quality of life of blind people. Through the combination of innovative technology from the medical device, IT and micro systems fields, a new class of active medical products has been created allowing, amongst other things, blind people to regain modest visual perception. The company was founded in 2002 and has 30 employees. The company has a process oriented quality management system in accordance with ISO 13485. | Medical Distributors | Director/Board Member | |
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member | |
Stanmore Implants Worldwide Ltd.
Stanmore Implants Worldwide Ltd. Medical SpecialtiesHealth Technology Stanmore Implants Worldwide, Ltd. designs and manufactures bespoke and modular implants for limb sparing and complex joint replacement. It provides massive endoprothesis tumour systems for orthopedic skeletal locations including the femur, tibia, knee, pelvis and humerus. The firm also offers computer assisted orthopedic surgeries. The company was founded on February 19, 1996 and is headquartered in Elstree, the United Kingdom. | Medical Specialties | Chairman | |
K Spine, Inc.
K Spine, Inc. Medical SpecialtiesHealth Technology K Spine, Inc. develops implantable medical devices for the treatment of spine disorders. It offers products for correcting an abnormal curvature of the spine. The company was founded by Danny Sachs and is headquartered in Minneapolis, MN. | Medical Specialties | Director/Board Member | |
PIXIUM VISION | Medical Specialties | Director/Board Member | |
Avitide, Inc.
Avitide, Inc. BiotechnologyHealth Technology Avitide, Inc. develops affinity purification solutions. Its technology enables development of chromatography resins via chemical synthesis which are not based on costly recombinant proteins. The company was founded by Errik B. Anderson, Warren Kett, Tillman U. Gerngross, Kevin Isett and Jonathan Sheller in 2012 and is headquartered in Lebanon, NH. | Biotechnology | Director/Board Member | |
Harvard College | College/University | Undergraduate Degree | |
OrbiMed Private Investments VI LP
OrbiMed Private Investments VI LP Investment ManagersFinance Orbimed Private Investments VI LP seeks investment opportunities companies located in North America and Europe. The fund targets companies operating in the fields of biopharmaceutical, medical device, diagnostics and healthcare services. It provides financing for seed stage, early stage, and later stage companies for both public and private companies with an investment size of $10 million to $75 million. | Investment Managers | Director/Board Member | |
Turnstone Biologics, Inc.
Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member | |
ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Thackray, Inc. | Chief Executive Officer | ||
Attenua, Inc.
Attenua, Inc. Pharmaceuticals: MajorHealth Technology Attenua, Inc. engages in the provision of biopharmaceutical services. The company was founded by Jing Liang and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member | |
Pionyr Immunotherapeutics, Inc.
Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Pionyr Immunotherapeutics, Inc. develops cancer immunotherapies. It targets the tumor microenvironment to enhance the body?s antitumor immunity. The company was founded by Max Krummel and Sachdev Sidhu in 2015 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
ESTABLISHMENT LABS HOLDINGS INC. | Medical Specialties | General Counsel Director of Finance/CFO | |
Meves Pharmaceuticals, Inc.
Meves Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Meves Pharmaceuticals, Inc. provides pharmaceutical products and services. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Modis Therapeutics, Inc.
Modis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Modis Therapeutics, Inc. is a biopharmaceutical company, which develops disease-modifying therapies for rare genetic diseases. Its product MT1621 is in clinical development for thymidine kinase 2 deficiency (TK2d), an inherited mitochondrial disease. The company was founded by Peter H. Barber and Daniel D. DiPietro in 2016 and is headquartered in Oakland, CA. | Miscellaneous Commercial Services | Director/Board Member | |
TURNSTONE BIOLOGICS CORP. | Biotechnology | Director/Board Member | |
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Charm Therapeutics Ltd.
Charm Therapeutics Ltd. BiotechnologyHealth Technology Charm Therapeutics Ltd. is a British London-based company that is discovering and developing small molecule medicines using its proprietary 3D deep learning-enabled platform, Dragonfold. The company aims to create life-changing therapies for difficult-to-drug targets in cancer and other disease areas. Charm Therapeutics has raised $70 million to date and is supported by high-quality international investors, including Orbimed, F-Prime Capital, General Catalyst, Khosla Ventures, Bristol Myers Squibb, NVIDIA, and Grep-VC. The company was founded in 2021 by Laksh Aithani and David Baker, with Laksh Aithani serving as the CEO since then. | Biotechnology | Director/Board Member | |
ENLIVEN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Aer Therapeutics, Inc.
Aer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aer Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Raleigh, NC. The company's mission is to advance the treatment paradigm for mucus mediated lung diseases. The company is dedicated to delivering a therapeutic solution to patients suffering from muco-obstructive lung diseases, with their initial focus being on chronic obstructive pulmonary disease (COPD) and other muco-obstructive lung diseases to follow, including asthma, cystic fibrosis, and primary ciliary. The company was founded by John Fahy, and the CEO is Jim Shaffer. | Pharmaceuticals: Major | Director/Board Member | |
Charm Therapeutics, Inc. | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 30 |
Verenigd Koninkrijk | 14 |
Frankrijk | 5 |
Zweden | 2 |
Zwitserland | 2 |
Sectoraal
Health Technology | 32 |
Consumer Services | 6 |
Commercial Services | 5 |
Finance | 4 |
Electronic Technology | 3 |
Operationeel
Director/Board Member | 114 |
Corporate Officer/Principal | 33 |
Independent Dir/Board Member | 32 |
Chairman | 16 |
Chief Executive Officer | 15 |
Sterkste connecties
Insiders | |
---|---|
Timothy Haines | 36 |
Nicholas Simon | 33 |
Rishi Gupta | 29 |
R. Greer | 23 |
Kevin O'Boyle | 21 |
Jeffrey M. Nugent | 20 |
Charles Huiner | 13 |
Renee Gaeta | 9 |
Matthew Pigeon | 7 |
Oliver Bennett | 7 |
Dan Carlisle | 6 |
Deborah Bettencourt | 5 |
Rosalyn Cole d’Incelli | 5 |
- Beurs
- Insiders
- Joel S. Smith
- Bedrijfsconnecties